Patients
15.8 % of adults
Smoking (adults), US, 2024 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
US Smoking Cessation Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$571.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.97 Bn | — | — |
| 2025 (base) | $2.03 Bn | +$55.2 Mn | — |
| 2026 (forecast) | $2.08 Bn | +$56.8 Mn | +2.8% |
| 2027 (forecast) | $2.14 Bn | +$58.3 Mn | +5.7% |
| 2028 (forecast) | $2.20 Bn | +$60.0 Mn | +8.6% |
| 2029 (forecast) | $2.26 Bn | +$61.7 Mn | +11.7% |
| 2030 (forecast) | $2.33 Bn | +$63.4 Mn | +14.8% |
| 2031 (forecast) | $2.39 Bn | +$65.2 Mn | +18% |
| 2032 (forecast) | $2.46 Bn | +$67.0 Mn | +21.3% |
| 2033 (forecast) | $2.53 Bn | +$68.9 Mn | +24.7% |
| 2034 (forecast) | $2.60 Bn | +$70.8 Mn | +28.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $2.03 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.60 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 2.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, form and distribution channel (see all) |
| Key players | Haleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc, Cipla Inc. (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026.Source: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Smoking cessation products help people quit smoking, including nicotine patches, gums, sprays, medicines and quit apps.
Key segments of the smoking Cessation Products market include product (Nicotine Replacement Therapy, Prescription Drugs and Digital Quit Programs) and form (Patches, Gum and Lozenges and Sprays and Inhalers).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.
Ready-to-use formulations, biosimilars and supply security programmes give the smoking Cessation Products market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the smoking Cessation Products market.
The smoking Cessation Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead.[1] Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products.[2] Smoking (adults): 15.8% of adults in 2024, the latest WHO figure for the US.[3]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Smoking (adults) (% of adults). Retrieved 15 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern smoking Cessation Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.
What doctors and scientists are doing in Smoking Cessation Products right now, from free public sources.
15.8 % of adults
Smoking (adults), US, 2024 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Smoking (adults) (% of adults). Retrieved 15 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Medical Devices · US
Medical Devices · US
Medical Devices · US
Medical Devices · US
Pharmaceuticals · US
Medical Devices · US